{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:25:37Z","timestamp":1793618737440,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40257-023-00789-1","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T14:02:12Z","timestamp":1686924132000},"page":"681-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Targeting Inflammation in Acne: Current Treatments and Future Prospects"],"prefix":"10.1007","volume":"24","author":[{"given":"Sebastian","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vecerek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-4404","authenticated-orcid":false,"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"1","key":"789_CR1","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1038\/s41598-020-62715-3","volume":"10","author":"AHS Heng","year":"2020","unstructured":"Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. https:\/\/doi.org\/10.1038\/s41598-020-62715-3.","journal-title":"Sci Rep"},{"issue":"1","key":"789_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","volume":"30","author":"S Knutsen-Larson","year":"2012","unstructured":"Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP. Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin. 2012;30(1):99\u2013106. https:\/\/doi.org\/10.1016\/j.det.2011.09.001.","journal-title":"Dermatol Clin"},{"issue":"9859","key":"789_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2163\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(12)61729-2.","journal-title":"The Lancet"},{"issue":"3","key":"789_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","volume":"55","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004. J Am Acad Dermatol. 2006;55(3):490\u2013500. https:\/\/doi.org\/10.1016\/j.jaad.2006.05.048.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"789_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1440-0960.1997.tb01126.x","volume":"38","author":"V Stathakis","year":"1997","unstructured":"Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 1997;38(3):115\u201323. https:\/\/doi.org\/10.1111\/j.1440-0960.1997.tb01126.x.","journal-title":"Australas J Dermatol"},{"issue":"3","key":"789_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris: Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474\u201385. https:\/\/doi.org\/10.1111\/bjd.12149.","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"789_CR7","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","volume":"131","author":"LF Eichenfield","year":"2013","unstructured":"Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(Suppl 3):S163-186. https:\/\/doi.org\/10.1542\/peds.2013-0490B.","journal-title":"Pediatrics"},{"issue":"2","key":"789_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jaad.2020.02.040","volume":"83","author":"DV Samuels","year":"2020","unstructured":"Samuels DV, Rosenthal R, Lin R, Chaudhari S, Natsuaki MN. Acne vulgaris and risk of depression and anxiety: a meta-analytic review. J Am Acad Dermatol. 2020;83(2):532\u201341. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.040.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"789_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/jocd.12708","volume":"18","author":"F \u00d6zyay Ero\u011flu","year":"2019","unstructured":"\u00d6zyay Ero\u011flu F, Aktepe E, Erturan \u0130. The evaluation of psychiatric comorbidity, self-injurious behavior, suicide probability, and other associated psychiatric factors (lonileness, self-esteem, life satisfaction) in adolescents with acne: a clinical pilot study. J Cosmet Dermatol. 2019;18(3):916\u201321. https:\/\/doi.org\/10.1111\/jocd.12708.","journal-title":"J Cosmet Dermatol"},{"issue":"12","key":"789_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1440-1754.2006.00979.x","volume":"42","author":"D Purvis","year":"2006","unstructured":"Purvis D, Robinson E, Merry S, Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediatr Child Health. 2006;42(12):793\u20136. https:\/\/doi.org\/10.1111\/j.1440-1754.2006.00979.x.","journal-title":"J Paediatr Child Health"},{"key":"789_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14374","volume":"31","author":"B Dr\u00e9no","year":"2017","unstructured":"Dr\u00e9no B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31:8\u201312. https:\/\/doi.org\/10.1111\/jdv.14374.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"789_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"TX Cong","year":"2019","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019;311(5):337\u201349. https:\/\/doi.org\/10.1007\/s00403-019-01908-x.","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"789_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1600-0625.2009.00890.x","volume":"18","author":"I Kurokawa","year":"2009","unstructured":"Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18(10):821\u201332. https:\/\/doi.org\/10.1111\/j.1600-0625.2009.00890.x.","journal-title":"Exp Dermatol"},{"issue":"2","key":"789_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1610-0387.2010.07344.x","volume":"8","author":"BC Melnik","year":"2010","unstructured":"Melnik BC. FoxO1 - the key for the pathogenesis and therapy of acne? JDDG J Dtsch Dermatol Ges. 2010;8(2):105\u201314. https:\/\/doi.org\/10.1111\/j.1610-0387.2010.07344.x.","journal-title":"JDDG J Dtsch Dermatol Ges."},{"issue":"3","key":"789_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/09546634.2019.1654075","volume":"32","author":"N Hazarika","year":"2021","unstructured":"Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatol Treat. 2021;32(3):277\u201385. https:\/\/doi.org\/10.1080\/09546634.2019.1654075.","journal-title":"J Dermatol Treat"},{"key":"789_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","volume":"172","author":"JKL Tan","year":"2015","unstructured":"Tan JKL, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172:3\u201312. https:\/\/doi.org\/10.1111\/bjd.13462.","journal-title":"Br J Dermatol"},{"issue":"1","key":"789_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40257-020-00542-y","volume":"22","author":"H Baldwin","year":"2021","unstructured":"Baldwin H, Tan J. Effects of diet on acne and its response to treatment. Am J Clin Dermatol. 2021;22(1):55\u201365. https:\/\/doi.org\/10.1007\/s40257-020-00542-y.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"789_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2133.2008.08959.x","volume":"160","author":"R Ganceviciene","year":"2009","unstructured":"Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160(2):345\u201352. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08959.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"789_CR19","first-page":"422","volume":"12","author":"M Toyoda","year":"2002","unstructured":"Toyoda M, Nakamura M, Morohashi M. Neuropeptides and sebaceous glands. Eur J Dermatol EJD. 2002;12(5):422\u20137.","journal-title":"Eur J Dermatol EJD."},{"issue":"3","key":"789_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2133.2006.07671.x","volume":"156","author":"E Makrantonaki","year":"2007","unstructured":"Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5?-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156(3):428\u201332. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07671.x.","journal-title":"Br J Dermatol"},{"key":"789_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.12688\/f1000research.25588.1","volume":"9","author":"I Kurokawa","year":"2020","unstructured":"Kurokawa I, Nakase K. Recent advances in understanding and managing acne. F1000Research. 2020;9:792. https:\/\/doi.org\/10.12688\/f1000research.25588.1.","journal-title":"F1000Research."},{"issue":"5","key":"789_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jdv.12298","volume":"28","author":"CC Zouboulis","year":"2014","unstructured":"Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527\u201332. https:\/\/doi.org\/10.1111\/jdv.12298.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"73","key":"789_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abo2787","volume":"7","author":"TH Do","year":"2022","unstructured":"Do TH, Ma F, Andrade PR, et al. TREM2 macrophages induced by human lipids drive inflammation in acne lesions. Sci Immunol. 2022;7(73):1\u201316. https:\/\/doi.org\/10.1126\/sciimmunol.abo2787.","journal-title":"Sci Immunol."},{"issue":"3","key":"789_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/microorganisms9030628","volume":"9","author":"M Rozas","year":"2021","unstructured":"Rozas M, de Hart RA, Fabrega MJ, et al. From dysbiosis to healthy skin: major contributions of Cutibacterium acnes to skin homeostasis. Microorganisms. 2021;9(3):628\u201345. https:\/\/doi.org\/10.3390\/microorganisms9030628.","journal-title":"Microorganisms."},{"key":"789_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"B Dr\u00e9no","year":"2018","unstructured":"Dr\u00e9no B, P\u00e9castaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes ) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32:5\u201314. https:\/\/doi.org\/10.1111\/jdv.15043.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"S1","key":"789_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40257-020-00531-1","volume":"21","author":"B Dr\u00e9no","year":"2020","unstructured":"Dr\u00e9no B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21(S1):18\u201324. https:\/\/doi.org\/10.1007\/s40257-020-00531-1.","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"789_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/jcm8070987","volume":"8","author":"Lee","year":"2019","unstructured":"Lee, Byun, Kim. Potential role of the microbiome in acne: a comprehensive review. J Clin Med. 2019;8(7):987\u20131011. https:\/\/doi.org\/10.3390\/jcm8070987.","journal-title":"J Clin Med"},{"issue":"8","key":"789_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2340\/00015555-2968","volume":"98","author":"Y Deng","year":"2018","unstructured":"Deng Y, Wang H, Zhou J, Mou Y, Wang G, Xiong X. Patients with acne vulgaris have a distinct gut microbiota in comparison with healthy controls. Acta Derm Venereol. 2018;98(8):783\u201390. https:\/\/doi.org\/10.2340\/00015555-2968.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"789_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/exd.12885","volume":"25","author":"G Monfrecola","year":"2016","unstructured":"Monfrecola G, Lembo S, Caiazzo G, et al. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients\u2019 skin. Exp Dermatol. 2016;25(2):153\u20135. https:\/\/doi.org\/10.1111\/exd.12885.","journal-title":"Exp Dermatol"},{"issue":"3","key":"789_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"J Kim","year":"2002","unstructured":"Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535\u201341. https:\/\/doi.org\/10.4049\/jimmunol.169.3.1535.","journal-title":"J Immunol"},{"issue":"8","key":"789_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105238","volume":"9","author":"HL Kelh\u00e4l\u00e4","year":"2014","unstructured":"Kelh\u00e4l\u00e4 HL, Palatsi R, Fyhrquist N, et al. IL-17\/Th17 pathway is activated in acne lesions. PLoS ONE. 2014;9(8): e105238. https:\/\/doi.org\/10.1371\/journal.pone.0105238.","journal-title":"PLoS ONE"},{"issue":"1","key":"789_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","volume":"135","author":"M Kistowska","year":"2015","unstructured":"Kistowska M, Meier B, Proust T, et al. Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110\u20138. https:\/\/doi.org\/10.1038\/jid.2014.290.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"789_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","volume":"71","author":"EB Koo","year":"2014","unstructured":"Koo EB, Petersen TD, Kimball AB. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. J Am Acad Dermatol. 2014;71(3):450\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.051.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"789_CR34","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"789_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","volume":"115","author":"M Muhlemann","year":"1986","unstructured":"Muhlemann M, Carter G, Cream J, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115(2):227\u201332. https:\/\/doi.org\/10.1111\/j.1365-2133.1986.tb05722.x.","journal-title":"Br J Dermatol"},{"issue":"2\u20133","key":"789_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000471799","volume":"233","author":"R Grandhi","year":"2017","unstructured":"Grandhi R, Alikhan A. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatol Basel Switz. 2017;233(2\u20133):141\u20134. https:\/\/doi.org\/10.1159\/000471799.","journal-title":"Dermatol Basel Switz."},{"issue":"4","key":"789_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1684\/ejd.2017.3062","volume":"27","author":"A Isvy-Joubert","year":"2017","unstructured":"Isvy-Joubert A, Nguyen JM, Gaultier A, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol EJD. 2017;27(4):393\u20138. https:\/\/doi.org\/10.1684\/ejd.2017.3062.","journal-title":"Eur J Dermatol EJD."},{"issue":"6","key":"789_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(6):621\u201330. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0465.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"789_CR39","first-page":"563","volume":"18","author":"A Mazzetti","year":"2019","unstructured":"Mazzetti A, Moro L, Gerloni M, Cartwright M. Pharmacokinetic profile, safety, and tolerability of clascoterone (cortexolone 17-alpha propionate, cb-03-01) topical cream, 1% in subjects with acne vulgaris: an open-label phase 2a study. J Drugs Dermatol JDD. 2019;18(6):563\u20138.","journal-title":"J Drugs Dermatol JDD."},{"issue":"6","key":"789_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamadermatol.2020.0464","volume":"156","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS. A new class of topical acne treatment addressing the hormonal pathogenesis of acne. JAMA Dermatol. 2020;156(6):619\u201320. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0464.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"789_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","volume":"23","author":"VD Callender","year":"2022","unstructured":"Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022;23(1):69\u201381. https:\/\/doi.org\/10.1007\/s40257-021-00643-2.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"789_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G, et al. Randomized phase 3 evaluation of trifarotene 50 \u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.044.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"789_CR43","first-page":"305","volume":"87","author":"AW Lucky","year":"2011","unstructured":"Lucky AW, Sugarman J. Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1% in young adolescents with acne: a post hoc analysis of efficacy and tolerability data. Cutis. 2011;87(6):305\u201310.","journal-title":"Cutis"},{"issue":"2","key":"789_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jaad.2016.03.019","volume":"75","author":"TJ Hansen","year":"2016","unstructured":"Hansen TJ, Lucking S, Miller JJ, Kirby JS, Thiboutot DM, Zaenglein AL. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol. 2016;75(2):323\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2016.03.019.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"789_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaad.2019.06.025","volume":"82","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2020;82(1):72\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.025.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"789_CR46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamadermatol.2022.2044","volume":"158","author":"E Xia","year":"2022","unstructured":"Xia E, Han J, Faletsky A, et al. Isotretinoin laboratory monitoring in acne treatment: a delphi consensus study. JAMA Dermatol. 2022;158(8):942\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2022.2044.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"789_CR47","first-page":"417","volume":"82","author":"JJ Leyden","year":"2008","unstructured":"Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008;82(6):417\u201321.","journal-title":"Cutis"},{"issue":"4","key":"789_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/s0190-9622(97)70177-4","volume":"37","author":"DP Lookingbill","year":"1997","unstructured":"Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol. 1997;37(4):590\u20135. https:\/\/doi.org\/10.1016\/s0190-9622(97)70177-4.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"789_CR49","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13555-019-00320-7","volume":"9","author":"N Zhang","year":"2019","unstructured":"Zhang N, Yuan R, Xin KZ, Lu Z, Ma Y. Antimicrobial susceptibility, biotypes and phylotypes of clinical cutibacterium (formerly propionibacterium) acnes strains isolated from acne patients: an observational study. Dermatol Ther. 2019;9(4):735\u201346. https:\/\/doi.org\/10.1007\/s13555-019-00320-7.","journal-title":"Dermatol Ther"},{"issue":"1","key":"789_CR50","first-page":"15","volume":"12","author":"CW Lynde","year":"2014","unstructured":"Lynde CW, Andriessen A. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skinmed. 2014;12(1):15\u201321.","journal-title":"Skinmed."},{"issue":"2","key":"789_CR51","first-page":"197","volume":"15","author":"AF Alexis","year":"2016","unstructured":"Alexis AF, Burgess C, Callender VD, et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color. J Drugs Dermatol JDD. 2016;15(2):197\u2013204.","journal-title":"J Drugs Dermatol JDD."},{"issue":"12","key":"789_CR52","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1001\/archdermatol.2008.518","volume":"144","author":"WW Piette","year":"2008","unstructured":"Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Arch Dermatol. 2008;144(12):1564\u201370. https:\/\/doi.org\/10.1001\/archdermatol.2008.518.","journal-title":"Arch Dermatol"},{"issue":"1","key":"789_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2018.08.020","volume":"80","author":"LS Gold","year":"2019","unstructured":"Gold LS, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart IA. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies. J Am Acad Dermatol. 2019;80(1):168\u201377. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.020.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"789_CR54","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory Hyperpigmentation. J Clin Aesthetic Dermatol. 2010;3(7):20\u201331.","journal-title":"J Clin Aesthetic Dermatol."},{"issue":"6","key":"789_CR55","first-page":"581","volume":"14","author":"A Moore","year":"2015","unstructured":"Moore A, Ling M, Bucko A, Manna V, Rueda MJ. Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded Controlled Study. J Drugs Dermatol JDD. 2015;14(6):581\u20136.","journal-title":"J Drugs Dermatol JDD."},{"issue":"5","key":"789_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamadermatol.2018.0110","volume":"154","author":"P Posadzki","year":"2018","unstructured":"Posadzki P, Car J. Light therapies for acne. JAMA Dermatol. 2018;154(5):597\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0110.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"789_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jocd.13197","volume":"19","author":"X Tang","year":"2020","unstructured":"Tang X, Li C, Ge S, Chen Z, Lu L. Efficacy of photodynamic therapy for the treatment of inflammatory acne vulgaris: a systematic review and meta-analysis. J Cosmet Dermatol. 2020;19(1):10\u201321. https:\/\/doi.org\/10.1111\/jocd.13197.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"789_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjd.21739","volume":"187","author":"I Mavranezouli","year":"2022","unstructured":"Mavranezouli I, Daly CH, Welton NJ, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187(5):639\u201349. https:\/\/doi.org\/10.1111\/bjd.21739.","journal-title":"Br J Dermatol"},{"issue":"5","key":"789_CR59","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1046\/j.1365-2133.2000.03481.x","volume":"142","author":"P Papageorgiou","year":"2000","unstructured":"Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142(5):973\u20138. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03481.x.","journal-title":"Br J Dermatol"},{"issue":"7","key":"789_CR60","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/lsm.20533","volume":"39","author":"W Lim","year":"2007","unstructured":"Lim W, Lee S, Kim I, et al. The anti-inflammatory mechanism of 635 nm light-emitting-diode irradiation compared with existing COX inhibitors. Lasers Surg Med. 2007;39(7):614\u201321. https:\/\/doi.org\/10.1002\/lsm.20533.","journal-title":"Lasers Surg Med"},{"issue":"7","key":"789_CR61","first-page":"627","volume":"7","author":"NA Sami","year":"2008","unstructured":"Sami NA, Attia AT, Badawi AM. Phototherapy in the treatment of acne vulgaris. J Drugs Dermatol JDD. 2008;7(7):627\u201332.","journal-title":"J Drugs Dermatol JDD."},{"issue":"5","key":"789_CR62","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/phpp.12769","volume":"38","author":"J Li","year":"2022","unstructured":"Li J, Li J, Zhang L, et al. Comparison of red light and blue light therapies for mild-to-moderate acne vulgaris: a randomized controlled clinical study. Photodermatol Photoimmunol Photomed. 2022;38(5):459\u201364. https:\/\/doi.org\/10.1111\/phpp.12769.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"6","key":"789_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1524-4725.2007.33142.x","volume":"33","author":"SE Chang","year":"2007","unstructured":"Chang SE, Ahn SJ, Rhee DY, et al. Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530- to 750-nm filter. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2007;33(6):676\u20139. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33142.x.","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al."},{"key":"789_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.12418","volume":"30","author":"MT Barakat","year":"2017","unstructured":"Barakat MT, Moftah NH, El Khayyat MAM, Abdelhakim ZA. Significant reduction of inflammation and sebaceous glands size in acne vulgaris lesions after intense pulsed light treatment. Dermatol Ther. 2017;30:1\u20135. https:\/\/doi.org\/10.1111\/dth.12418.","journal-title":"Dermatol Ther"},{"issue":"2","key":"789_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/14764172.2013.864198","volume":"16","author":"M Taylor","year":"2014","unstructured":"Taylor M, Porter R, Gonzalez M. Intense pulsed light may improve inflammatory acne through TNF-\u03b1 down-regulation. J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol. 2014;16(2):96\u2013103. https:\/\/doi.org\/10.3109\/14764172.2013.864198.","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol."},{"issue":"7","key":"789_CR66","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03525.x","volume":"24","author":"YS Choi","year":"2010","unstructured":"Choi YS, Suh HS, Yoon MY, Min SU, Lee DH, Suh DH. Intense pulsed light vs pulsed-dye laser in the treatment of facial acne: a randomized split-face trial. J Eur Acad Dermatol Venereol JEADV. 2010;24(7):773\u201380. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03525.x.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"9393","key":"789_CR67","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0140-6736(03)14629-6","volume":"362","author":"ED Seaton","year":"2003","unstructured":"Seaton ED, Charakida A, Mouser PE, Grace I, Clement RM, Chu AC. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet Lond Engl. 2003;362(9393):1347\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(03)14629-6.","journal-title":"Lancet Lond Engl."},{"issue":"5","key":"789_CR68","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1524-4725.2007.33113.x","volume":"33","author":"NS Uebelhoer","year":"2007","unstructured":"Uebelhoer NS, Bogle MA, Dover JS, Arndt KA, Rohrer TE. Comparison of stacked pulses versus double-pass treatments of facial acne with a 1,450-nm laser. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2007;33(5):552\u20139. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33113.x.","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al."},{"issue":"6","key":"789_CR69","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/jocd.12788","volume":"17","author":"HH Kwon","year":"2018","unstructured":"Kwon HH, Choi SC, Jung JY, Bae YI, Park GH. Comparison of novel dual mode vs conventional single pass of a 1450-nm diode laser in the treatment of acne vulgaris for Korean patients: A 20-week prospective, randomized, split-face study. J Cosmet Dermatol. 2018;17(6):1063\u20138. https:\/\/doi.org\/10.1111\/jocd.12788.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"789_CR70","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/jdv.14881","volume":"32","author":"FMC de Vries","year":"2018","unstructured":"de Vries FMC, Meulendijks AM, Driessen RJB, van Dooren AA, Tjin EPM, van de Kerkhof PCM. The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: A systematic review and best-evidence synthesis. J Eur Acad Dermatol Venereol JEADV. 2018;32(7):1195\u2013203. https:\/\/doi.org\/10.1111\/jdv.14881.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"key":"789_CR71","unstructured":"Cutera. AviClear. Cutera Aesthetic Solutions. Published 2023. Accessed January 14, 2023. https:\/\/www.cutera.com\/solutions\/aviclear\/"},{"issue":"9","key":"789_CR72","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/s10103-022-03645-6","volume":"37","author":"MG Scopelliti","year":"2022","unstructured":"Scopelliti MG, Kothare A, Karavitis M. A novel 1726-nm laser system for safe and effective treatment of acne vulgaris. Lasers Med Sci. 2022;37(9):3639\u201347. https:\/\/doi.org\/10.1007\/s10103-022-03645-6.","journal-title":"Lasers Med Sci"},{"key":"789_CR73","unstructured":"Kaitlyn Bader AE. FDA Clears Accure Laser System for Acne Treatment. 2022;44. Accessed January 14, 2023. https:\/\/www.dermatologytimes.com\/view\/fda-clears-accure-laser-system-for-acne-treatment"},{"key":"789_CR74","unstructured":"Brunk, D. Laser and light devices for acne treatment continue to advance. Published 2022. Accessed January 14, 2023. https:\/\/www.mdedge.com\/dermatology\/article\/259752\/acne\/laser-and-light-devices-acne-treatment-continue-advance"},{"issue":"7","key":"789_CR75","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/jid.2015.89","volume":"135","author":"DY Paithankar","year":"2015","unstructured":"Paithankar DY, Sakamoto FH, Farinelli WA, et al. Acne treatment based on selective photothermolysis of sebaceous follicles with topically delivered light-absorbing gold microparticles. J Invest Dermatol. 2015;135(7):1727\u201334. https:\/\/doi.org\/10.1038\/jid.2015.89.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"789_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.13189","volume":"33","author":"KY Park","year":"2020","unstructured":"Park KY, Han HS, Hong JY, Seo SJ, Lee SJ. Gold nanoshell-mediated photothermal therapy for acne vulgaris. Dermatol Ther. 2020;33(1):1\u20133. https:\/\/doi.org\/10.1111\/dth.13189.","journal-title":"Dermatol Ther"},{"issue":"6","key":"789_CR77","doi-asserted-by":"publisher","first-page":"666","DOI":"10.36849\/JDD.2021.5762","volume":"20","author":"K Artounian","year":"2021","unstructured":"Artounian K, Bundogji N, Hoss E, Boen M. Applications of gold and silver nanoparticles in the treatment of acne vulgaris: a systematic review. J Drugs Dermatol JDD. 2021;20(6):666\u201370. https:\/\/doi.org\/10.36849\/JDD.2021.5762.","journal-title":"J Drugs Dermatol JDD."},{"issue":"8","key":"789_CR78","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/lsm.23099","volume":"51","author":"CSK Fuchs","year":"2019","unstructured":"Fuchs CSK, Bay C, Adatto M, Lomholt H, Haedersdal M. Acne treatment with light absorbing gold microparticles and optical pulses: an open-label european multi-centered study in moderate to moderately severe acne vulgaris patients. Lasers Surg Med. 2019;51(8):686\u201393. https:\/\/doi.org\/10.1002\/lsm.23099.","journal-title":"Lasers Surg Med"},{"issue":"3","key":"789_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.14918","volume":"34","author":"DH Suh","year":"2021","unstructured":"Suh DH, Park TJ, Jeong JY, et al. Photothermal therapy using gold nanoparticles for acne in Asian patients: a preliminary study. Dermatol Ther. 2021;34(3):1\u20134. https:\/\/doi.org\/10.1111\/dth.14918.","journal-title":"Dermatol Ther"},{"issue":"5","key":"789_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4062\/biomolther.2020.004","volume":"28","author":"G Yang","year":"2020","unstructured":"Yang G, Lee SJ, Kang HC, et al. Repurposing auranofin, an anti-rheumatic gold compound, to treat acne vulgaris by targeting the NLRP3 inflammasome. Biomol Ther. 2020;28(5):437\u201342. https:\/\/doi.org\/10.4062\/biomolther.2020.004.","journal-title":"Biomol Ther."},{"issue":"3","key":"789_CR81","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1524-4725.2011.02267.x","volume":"38","author":"SJ Lee","year":"2012","unstructured":"Lee SJ, Goo JW, Shin J, et al. Use of fractionated microneedle radiofrequency for the treatment of inflammatory acne vulgaris in 18 korean patients. Dermatol Surg. 2012;38(3):400\u20135. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02267.x.","journal-title":"Dermatol Surg"},{"issue":"7","key":"789_CR82","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/1346-8138.12471","volume":"41","author":"ST Kim","year":"2014","unstructured":"Kim ST, Lee KH, Sim HJ, Suh KS, Jang MS. Treatment of acne vulgaris with fractional radiofrequency microneedling. J Dermatol. 2014;41(7):586\u201391. https:\/\/doi.org\/10.1111\/1346-8138.12471.","journal-title":"J Dermatol"},{"issue":"10","key":"789_CR83","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/DSS.0000000000002364","volume":"46","author":"J Kim","year":"2020","unstructured":"Kim J, Lee YI, Kim J, Jung JY, Lee WJ, Lee JH. Safety of combined fractional microneedle radiofrequency and CO2 as an early intervention for inflammatory acne and scarring treated with concomitant isotretinoin. Dermatol Surg. 2020;46(10):e71\u20137. https:\/\/doi.org\/10.1097\/DSS.0000000000002364.","journal-title":"Dermatol Surg"},{"issue":"10","key":"789_CR84","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1111\/jocd.15171","volume":"21","author":"J Kim","year":"2022","unstructured":"Kim J, Jongudomsombat T, Lee YI, et al. Combined use of energy-based interventions with low-dose isotretinoin for the treatment of inflammatory acne: An retrospective cohort analysis. J Cosmet Dermatol. 2022;21(10):4383\u201391. https:\/\/doi.org\/10.1111\/jocd.15171.","journal-title":"J Cosmet Dermatol"},{"key":"789_CR85","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","volume":"121","author":"D Yang","year":"2021","unstructured":"Yang D, Chen M, Sun Y, et al. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021;121:119\u201333. https:\/\/doi.org\/10.1016\/j.actbio.2020.12.004.","journal-title":"Acta Biomater"},{"key":"789_CR86","doi-asserted-by":"publisher","DOI":"10.25251\/skin.4.supp.90","volume":"4","author":"J Del Rosso","year":"2020","unstructured":"Del Rosso J, Gold L, Draelos Z, Raoof T, Hooper D, Stuart I. A prospective, multicenter, randomized, double-blind, vehicle-controlled phase 2 study to evaluate the safety and efficacy of a combination of 3% minocycline and 0.3% adapalene topical foam formulation for the treatment of moderate-to-severe acne. SKIN J Cutan Med. 2020;4: s90. https:\/\/doi.org\/10.25251\/skin.4.supp.90.","journal-title":"SKIN J Cutan Med."},{"issue":"2","key":"789_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40257-021-00666-9","volume":"23","author":"L Drake","year":"2022","unstructured":"Drake L, Reyes-Hadsall S, Barbieri JS, Mostaghimi A. New developments in topical acne therapy. Am J Clin Dermatol. 2022;23(2):125\u201336. https:\/\/doi.org\/10.1007\/s40257-021-00666-9.","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"789_CR88","first-page":"E53","volume":"15","author":"JQ Del Rosso","year":"2022","unstructured":"Del Rosso JQ, Johnson SM, Schlesinger T, et al. A randomized, controlled trial of trifarotene plus doxycycline for severe acne vulgaris. J Clin Aesthetic Dermatol. 2022;15(7):E53\u20139.","journal-title":"J Clin Aesthetic Dermatol."},{"issue":"9","key":"789_CR89","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1172\/JCI64628","volume":"124","author":"A Ol\u00e1h","year":"2014","unstructured":"Ol\u00e1h A, T\u00f3th BI, Borb\u00edr\u00f3 I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest. 2014;124(9):3713\u201324. https:\/\/doi.org\/10.1172\/JCI64628.","journal-title":"J Clin Invest"},{"issue":"8","key":"789_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202933","volume":"13","author":"S Jin","year":"2018","unstructured":"Jin S, Lee MY. The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes. PLoS ONE. 2018;13(8): e0202933. https:\/\/doi.org\/10.1371\/journal.pone.0202933.","journal-title":"PLoS ONE"},{"key":"789_CR91","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2147\/JIR.S355489","volume":"15","author":"N Peyravian","year":"2022","unstructured":"Peyravian N, Deo S, Daunert S, Jimenez JJ. The anti-inflammatory effects of cannabidiol (CBD) on acne. J Inflamm Res. 2022;15:2795\u2013801. https:\/\/doi.org\/10.2147\/JIR.S355489.","journal-title":"J Inflamm Res"},{"key":"789_CR92","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.2147\/JIR.S374692","volume":"15","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Jin S, Fan X, et al. Cannabidiol inhibits inflammation induced by cutibacterium acnes-derived extracellular vesicles via activation of CB2 receptor in keratinocytes. J Inflamm Res. 2022;15:4573\u201383. https:\/\/doi.org\/10.2147\/JIR.S374692.","journal-title":"J Inflamm Res"},{"issue":"4","key":"789_CR93","first-page":"1389","volume":"28","author":"A Ali","year":"2015","unstructured":"Ali A, Akhtar N. The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. Pak J Pharm Sci. 2015;28(4):1389\u201395.","journal-title":"Pak J Pharm Sci"},{"key":"789_CR94","unstructured":"BiotechDispatch. Botanix progresses development plan for BTX 1503. biotechdispatch.com.au. Published 2020. Accessed December 14, 2022. https:\/\/biotechdispatch.com.au\/news\/botanix-progresses-development-plan-for-btx-1503"},{"issue":"2","key":"789_CR95","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ejh.13348","volume":"104","author":"J Cai","year":"2020","unstructured":"Cai J, Ribkoff J, Olson S, et al. The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2020;104(2):79\u201387. https:\/\/doi.org\/10.1111\/ejh.13348.","journal-title":"Eur J Haematol"},{"issue":"1","key":"789_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jocd.12026","volume":"12","author":"TW Tse","year":"2013","unstructured":"Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol. 2013;12(1):57\u201366. https:\/\/doi.org\/10.1111\/jocd.12026.","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"789_CR97","first-page":"753","volume":"19","author":"B Ebrahimi","year":"2014","unstructured":"Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci Off J Isfahan Univ Med Sci. 2014;19(8):753\u20137.","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci."},{"issue":"6","key":"789_CR98","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.jaad.2019.09.074","volume":"82","author":"D Jakhar","year":"2020","unstructured":"Jakhar D, Kaur I. Topical 5% tranexamic acid for acne-related postinflammatory erythema. J Am Acad Dermatol. 2020;82(6):e187\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.074.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"789_CR99","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1111\/jocd.14972","volume":"21","author":"A Charoenwattanayothin","year":"2022","unstructured":"Charoenwattanayothin A, Saiwichai T, Chaichalotornkul S. Adjunctive treatment for acne vulgaris by tranexamic acid. J Cosmet Dermatol. 2022;21(10):4515\u201322. https:\/\/doi.org\/10.1111\/jocd.14972.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"789_CR100","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/biomedicines10050931","volume":"10","author":"PA Grange","year":"2022","unstructured":"Grange PA, Ollagnier G, Beauvais Remigereau L, et al. A new topical candidate in acne treatment: characterization of the meclozine hydrochloride as an anti-inflammatory compound from in vitro to a preliminary clinical study. Biomedicines. 2022;10(5):931\u201351. https:\/\/doi.org\/10.3390\/biomedicines10050931.","journal-title":"Biomedicines."},{"issue":"1","key":"789_CR101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/antibiotics9010023","volume":"9","author":"KW Woodburn","year":"2020","unstructured":"Woodburn KW, Jaynes J, Clemens LE. Designed antimicrobial peptides for topical treatment of antibiotic resistant acne vulgaris. Antibiotics. 2020;9(1):23\u201331. https:\/\/doi.org\/10.3390\/antibiotics9010023.","journal-title":"Antibiotics"},{"issue":"4","key":"789_CR102","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/jocd.14300","volume":"21","author":"Z Ma","year":"2022","unstructured":"Ma Z, Kochergin N, Olisova O, Snarskaya E. Topical antimicrobial peptides in combined treatment of acne patients. J Cosmet Dermatol. 2022;21(4):1533\u20138. https:\/\/doi.org\/10.1111\/jocd.14300.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"789_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000439439","volume":"29","author":"C Richter","year":"2016","unstructured":"Richter C, Trojahn C, Hillmann K, et al. Reduction of inflammatory and noninflammatory lesions with topical tyrothricin 0.1% in the treatment of mild to severe acne papulopustulosa: a randomized controlled clinical trial. Skin Pharmacol Physiol. 2016;29(1):1\u20138. https:\/\/doi.org\/10.1159\/000439439.","journal-title":"Skin Pharmacol Physiol."},{"issue":"3","key":"789_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151184","volume":"11","author":"TL Brown","year":"2016","unstructured":"Brown TL, Petrovski S, Dyson ZA, Seviour R, Tucci J. The formulation of bacteriophage in a semi solid preparation for control of propionibacterium acnes growth. PLoS ONE. 2016;11(3): e0151184. https:\/\/doi.org\/10.1371\/journal.pone.0151184.","journal-title":"PLoS ONE"},{"issue":"1","key":"789_CR105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13555-018-0275-9","volume":"9","author":"DE Castillo","year":"2019","unstructured":"Castillo DE, Nanda S, Keri JE. Propionibacterium (Cutibacterium) acnes bacteriophage therapy in acne: current evidence and future perspectives. Dermatol Ther. 2019;9(1):19\u201331. https:\/\/doi.org\/10.1007\/s13555-018-0275-9.","journal-title":"Dermatol Ther"},{"issue":"6","key":"789_CR106","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/lam.13576","volume":"73","author":"M Shan","year":"2021","unstructured":"Shan M, Meng F, Zhou L, et al. Surfactin inhibits the growth of Propionibacterium acnes by destroying the cell wall and membrane. Lett Appl Microbiol. 2021;73(6):684\u201393. https:\/\/doi.org\/10.1111\/lam.13576.","journal-title":"Lett Appl Microbiol"},{"issue":"8","key":"789_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-022-03323-3","volume":"38","author":"X Chen","year":"2022","unstructured":"Chen X, Lu Y, Shan M, Zhao H, Lu Z, Lu Y. A mini-review: mechanism of antimicrobial action and application of surfactin. World J Microbiol Biotechnol. 2022;38(8):1\u201310. https:\/\/doi.org\/10.1007\/s11274-022-03323-3.","journal-title":"World J Microbiol Biotechnol"},{"issue":"2","key":"789_CR108","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00253-021-11719-8","volume":"106","author":"M Shan","year":"2022","unstructured":"Shan M, Meng F, Tang C, Zhou L, Lu Z, Lu Y. Surfactin-oleogel with therapeutic potential for inflammatory acne vulgaris induced by Propionibacterium acnes. Appl Microbiol Biotechnol. 2022;106(2):549\u201362. https:\/\/doi.org\/10.1007\/s00253-021-11719-8.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"789_CR109","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1172\/JCI119473","volume":"99","author":"FC Fang","year":"1997","unstructured":"Fang FC. Perspectives series: host\/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99(12):2818\u201325. https:\/\/doi.org\/10.1172\/JCI119473.","journal-title":"J Clin Invest"},{"issue":"6","key":"789_CR110","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1189\/jlb.1010550","volume":"89","author":"DA Wink","year":"2011","unstructured":"Wink DA, Hines HB, Cheng RYS, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011;89(6):873\u201391. https:\/\/doi.org\/10.1189\/jlb.1010550.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"789_CR111","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/jid.2015.277","volume":"135","author":"M Qin","year":"2015","unstructured":"Qin M, Landriscina A, Rosen JM, et al. Nitric oxide-releasing nanoparticles prevent propionibacterium acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. J Invest Dermatol. 2015;135(11):2723\u201331. https:\/\/doi.org\/10.1038\/jid.2015.277.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"789_CR112","first-page":"12","volume":"9","author":"H Baldwin","year":"2016","unstructured":"Baldwin H, Blanco D, McKeever C, et al. Results of a phase 2 efficacy and safety study with sb204, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris. J Clin Aesthetic Dermatol. 2016;9(8):12\u20138.","journal-title":"J Clin Aesthetic Dermatol."},{"issue":"1","key":"789_CR113","first-page":"011","volume":"3","author":"G Chernoff","year":"2020","unstructured":"Chernoff G. The utilization of a nitric oxide generating serum in the treatment of active acne and acne scarred patients. Int J Pharm Anal Acta. 2020;3(1):011\u20134.","journal-title":"Int J Pharm Anal Acta."},{"issue":"3","key":"789_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.13279","volume":"33","author":"A Goodarzi","year":"2020","unstructured":"Goodarzi A, Mozafarpoor S, Bodaghabadi M, Mohamadi M. The potential of probiotics for treating acne vulgaris: a review of literature on acne and microbiota. Dermatol Ther. 2020;33(3):1\u20136. https:\/\/doi.org\/10.1111\/dth.13279.","journal-title":"Dermatol Ther"},{"issue":"9","key":"789_CR115","first-page":"868","volume":"5","author":"WP Bowe","year":"2006","unstructured":"Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol JDD. 2006;5(9):868\u201370.","journal-title":"J Drugs Dermatol JDD."},{"issue":"4","key":"789_CR116","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.fct.2005.08.030","volume":"44","author":"S Oh","year":"2006","unstructured":"Oh S, Kim SH, Ko Y, et al. Effect of bacteriocin produced by Lactococcus sp HY 449 on skin-inflammatory bacteria. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2006;44(4):552\u20139. https:\/\/doi.org\/10.1016\/j.fct.2005.08.030.","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc."},{"issue":"9","key":"789_CR117","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1128\/IAI.00188-08","volume":"76","author":"C Cosseau","year":"2008","unstructured":"Cosseau C, Devine DA, Dullaghan E, et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun. 2008;76(9):4163\u201375. https:\/\/doi.org\/10.1128\/IAI.00188-08.","journal-title":"Infect Immun"},{"issue":"6","key":"789_CR118","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1684\/ejd.2010.1108","volume":"20","author":"A Gueniche","year":"2010","unstructured":"Gueniche A, Benyacoub J, Philippe D, et al. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol EJD. 2010;20(6):731\u20137. https:\/\/doi.org\/10.1684\/ejd.2010.1108.","journal-title":"Eur J Dermatol EJD."},{"issue":"1","key":"789_CR119","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00253-013-5394-8","volume":"98","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kuo S, Shu M, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol. 2014;98(1):411\u201324. https:\/\/doi.org\/10.1007\/s00253-013-5394-8.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"789_CR120","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12275-008-0179-y","volume":"47","author":"BS Kang","year":"2009","unstructured":"Kang BS, Seo JG, Lee GS, et al. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol Seoul Korea. 2009;47(1):101\u20139. https:\/\/doi.org\/10.1007\/s12275-008-0179-y.","journal-title":"J Microbiol Seoul Korea."},{"issue":"6","key":"789_CR121","first-page":"385","volume":"63","author":"N Muizzuddin","year":"2012","unstructured":"Muizzuddin N, Maher W, Sullivan M, Schnittger S, Mammone T. Physiological effect of a probiotic on skin. J Cosmet Sci. 2012;63(6):385\u201395.","journal-title":"J Cosmet Sci"},{"issue":"1","key":"789_CR122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pt.2020.10.005","volume":"37","author":"RJ Martin","year":"2021","unstructured":"Martin RJ, Robertson AP, Choudhary S. Ivermectin: an anthelmintic, an insecticide, and much more. Trends Parasitol. 2021;37(1):48\u201364. https:\/\/doi.org\/10.1016\/j.pt.2020.10.005.","journal-title":"Trends Parasitol"},{"issue":"2","key":"789_CR123","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5114\/ada.2018.75239","volume":"35","author":"UG Ak\u00e7\u0131nar","year":"2018","unstructured":"Ak\u00e7\u0131nar UG, \u00dcnal E, Do\u011fruman AF. Demodex spp. as a possible aetiopathogenic factor of acne and relation with acne severity and type. Adv Dermatol Allergol Dermatol Alergol. 2018;35(2):174\u201381. https:\/\/doi.org\/10.5114\/ada.2018.75239.","journal-title":"Adv Dermatol Allergol Dermatol Alergol."},{"issue":"1","key":"789_CR124","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5114\/ada.2019.82825","volume":"36","author":"W Bara\u0144ska-Rybak","year":"2019","unstructured":"Bara\u0144ska-Rybak W, Kowalska-Ol\u0119dzka E. New indications for topical ivermectin 1% cream: a case series study. Adv Dermatol Allergol Dermatol Alergol. 2019;36(1):58\u201362. https:\/\/doi.org\/10.5114\/ada.2019.82825.","journal-title":"Adv Dermatol Allergol Dermatol Alergol."},{"issue":"6","key":"789_CR125","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/jid.2015.40","volume":"135","author":"NW Schmidt","year":"2015","unstructured":"Schmidt NW, Agak GW, Deshayes S, et al. Pentobra: a potent antibiotic with multiple layers of selective antimicrobial mechanisms against propionibacterium acnes. J Invest Dermatol. 2015;135(6):1581\u20139. https:\/\/doi.org\/10.1038\/jid.2015.40.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"789_CR126","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ja.2015.4","volume":"68","author":"I Iscla","year":"2015","unstructured":"Iscla I, Wray R, Blount P, et al. A new antibiotic with potent activity targets MscL. J Antibiot (Tokyo). 2015;68(7):453\u201362. https:\/\/doi.org\/10.1038\/ja.2015.4.","journal-title":"J Antibiot (Tokyo)"},{"key":"789_CR127","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2147\/DDDT.S106462","volume":"10","author":"A Dinant","year":"2016","unstructured":"Dinant A, Boulos RA. Zolav\u00ae: a new antibiotic for the treatment of acne. Drug Des Devel Ther. 2016;10:1235\u201342. https:\/\/doi.org\/10.2147\/DDDT.S106462.","journal-title":"Drug Des Devel Ther."},{"issue":"2","key":"789_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001551","volume":"3","author":"T Nakatsuji","year":"2008","unstructured":"Nakatsuji T, Liu YT, Huang CP, Gallo RL, Huang CM. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS ONE. 2008;3(2): e1551. https:\/\/doi.org\/10.1371\/journal.pone.0001551.","journal-title":"PLoS ONE"},{"issue":"5","key":"789_CR129","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1586\/edm.10.42","volume":"5","author":"T Yen","year":"2010","unstructured":"Yen T, Yuan CY, Huang CM. Current status of acne vaccines. Expert Rev Dermatol. 2010;5(5):561\u20136. https:\/\/doi.org\/10.1586\/edm.10.42.","journal-title":"Expert Rev Dermatol"},{"issue":"11","key":"789_CR130","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.jid.2018.05.032","volume":"138","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hata TR, Tong YL, et al. The anti-inflammatory activities of propionibacterium acnes CAMP factor-targeted acne vaccines. J Invest Dermatol. 2018;138(11):2355\u201364. https:\/\/doi.org\/10.1016\/j.jid.2018.05.032.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"789_CR131","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/bjd.16071","volume":"179","author":"S Adamo","year":"2018","unstructured":"Adamo S, Nilsson J, Krebs A, et al. Successful treatment of SAPHO syndrome with apremilast. Br J Dermatol. 2018;179(4):959\u201362. https:\/\/doi.org\/10.1111\/bjd.16071.","journal-title":"Br J Dermatol"},{"issue":"8","key":"789_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.15637","volume":"35","author":"A S\u00e1nchez-Vel\u00e1zquez","year":"2022","unstructured":"S\u00e1nchez-Vel\u00e1zquez A, Falkenhain-L\u00f3pez D, Arroyo-Andr\u00e9s J, Montero-Men\u00e1rguez J, Garc\u00eda-Donoso C, Postigo-Llorente C. Apremilast: A novel adjuvant treatment for refractory isotretinoin-induced acne fulminans. Dermatol Ther. 2022;35(8):1\u20132. https:\/\/doi.org\/10.1111\/dth.15637.","journal-title":"Dermatol Ther"},{"issue":"19","key":"789_CR133","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3889\/oamjms.2019.718","volume":"7","author":"T Rahmayani","year":"2019","unstructured":"Rahmayani T, Putra IB, Jusuf NK. The effect of oral probiotic on the interleukin-10 serum levels of acne vulgaris. Open Access Maced J Med Sci. 2019;7(19):3249\u201352. https:\/\/doi.org\/10.3889\/oamjms.2019.718.","journal-title":"Open Access Maced J Med Sci."},{"issue":"2","key":"789_CR134","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2310\/7750.2012.12026","volume":"17","author":"GW Jung","year":"2013","unstructured":"Jung GW, Tse JE, Guiha I, Rao J. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg. 2013;17(2):114\u201322. https:\/\/doi.org\/10.2310\/7750.2012.12026.","journal-title":"J Cutan Med Surg"},{"key":"789_CR135","doi-asserted-by":"crossref","unstructured":"Rocha MAD da. The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. clinicaltrials.gov; 2022. Accessed December 14, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NC** T05216289","DOI":"10.21203\/rs.3.rs-2227654\/v1"},{"issue":"9","key":"789_CR136","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.nut.2010.05.011","volume":"26","author":"J Kim","year":"2010","unstructured":"Kim J, Ko Y, Park YK, Kim NI, Ha WK, Cho Y. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutr Burbank Los Angel Cty Calif. 2010;26(9):902\u20139. https:\/\/doi.org\/10.1016\/j.nut.2010.05.011.","journal-title":"Nutr Burbank Los Angel Cty Calif."},{"issue":"2","key":"789_CR137","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13555-021-00664-z","volume":"12","author":"F Rinaldi","year":"2022","unstructured":"Rinaldi F, Marotta L, Mascolo A, et al. Facial acne: a randomized, double-blind, placebo-controlled study on the clinical efficacy of a symbiotic dietary supplement. Dermatol Ther. 2022;12(2):577\u201389. https:\/\/doi.org\/10.1007\/s13555-021-00664-z.","journal-title":"Dermatol Ther"},{"issue":"11","key":"789_CR138","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/jamadermatol.2013.6678","volume":"149","author":"FL Sand","year":"2013","unstructured":"Sand FL, Thomsen SF. Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol. 2013;149(11):1306\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6678.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"789_CR139","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ced.12540","volume":"40","author":"ZZN Yiu","year":"2015","unstructured":"Yiu ZZN, Madan V, Griffiths CEM. Acne conglobata and adalimumab: use of tumour necrosis factor-\u03b1 antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol. 2015;40(4):383\u20136. https:\/\/doi.org\/10.1111\/ced.12540.","journal-title":"Clin Exp Dermatol"},{"key":"789_CR140","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jdcr.2021.05.029","volume":"14","author":"A Flora","year":"2021","unstructured":"Flora A, Holland R, Smith A, Frew JW. Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab). JAAD Case Rep. 2021;14:33\u20136. https:\/\/doi.org\/10.1016\/j.jdcr.2021.05.029.","journal-title":"JAAD Case Rep."},{"issue":"6","key":"789_CR141","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.211155","volume":"49","author":"G Wang","year":"2022","unstructured":"Wang G, Zhuo N, Li J. Off-label use of secukinumab: a potential therapeutic option for SAPHO syndrome. J Rheumatol. 2022;49(6):656. https:\/\/doi.org\/10.3899\/jrheum.211155.","journal-title":"J Rheumatol"},{"key":"789_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2022.2138691","volume":"2138691","author":"DM Thiboutot","year":"2022","unstructured":"Thiboutot DM, Craft N, Rissmann R, et al. Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne. J Dermatol Treat. 2022;2138691:1\u20137. https:\/\/doi.org\/10.1080\/09546634.2022.2138691.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"789_CR143","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5021\/ad.2022.34.3.216","volume":"34","author":"HS Han","year":"2022","unstructured":"Han HS, Jeong GJ, Lee HW, Shim JH, Seo SJ, Park KY. Innovative use of negative air ions as an alternative therapy for acne vulgaris: a report of three cases. Ann Dermatol. 2022;34(3):216\u201320. https:\/\/doi.org\/10.5021\/ad.2022.34.3.216.","journal-title":"Ann Dermatol"},{"issue":"8","key":"789_CR144","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1111\/jocd.15046","volume":"21","author":"H Qu","year":"2022","unstructured":"Qu H, Wang Y, Yang F, Wang G, Gao L, Li K. A randomized, controlled trial of intense pulsed light in combination with minocycline hydrochloride for the treatment of inflammatory acne vulgaris. J Cosmet Dermatol. 2022;21(8):3386\u201392. https:\/\/doi.org\/10.1111\/jocd.15046.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"789_CR145","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10103-020-03113-z","volume":"36","author":"Y Li","year":"2021","unstructured":"Li Y, Zhu J, Zhang Y, Liu X, Ye J. Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects. Lasers Med Sci. 2021;36(3):657\u201365. https:\/\/doi.org\/10.1007\/s10103-020-03113-z.","journal-title":"Lasers Med Sci"},{"issue":"2","key":"789_CR146","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","volume":"40","author":"H Chung","year":"2012","unstructured":"Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516\u201333. https:\/\/doi.org\/10.1007\/s10439-011-0454-7.","journal-title":"Ann Biomed Eng"},{"issue":"8","key":"789_CR147","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s10103-022-03606-z","volume":"37","author":"Y Li","year":"2022","unstructured":"Li Y, Xia J, Zhu Y, et al. Efficacy and safety of low-level light therapy by delicate pulsed light combined with low-dose oral isotretinoin for the treatment of acne vulgaris: a randomized split-face study. Lasers Med Sci. 2022;37(8):3221\u20139. https:\/\/doi.org\/10.1007\/s10103-022-03606-z.","journal-title":"Lasers Med Sci"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-023-00789-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T02:21:35Z","timestamp":1693016495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-023-00789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s40257-023-00789-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"30 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by SCELC, Statewide California Electronic Library Consortium.\u00a0No sources of funding were used to prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors contributed to the concept and planning of the work described and drafting and\/or critical revision of the manuscript. All authors approved the final submitted version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Dr. Elbuluk has served as a consultant to Galderma. Dr. Cruz and Dr. Vecerek have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}